Discovery of Novel Anti-cryptosporidial Activities From Natural Products by in vitro High-Throughput Phenotypic Screening

Cryptosporidium parvum is a globally distributed zoonotic protozoan parasite of both medical and veterinary importance. Nitazoxanide is the only FDA-approved drug to treat cryptosporidiosis in immunocompetent people, but it is not fully effective. There is no drug approved by FDA for use in immunoco...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Zi, Ma, Jingbo, Zhu, Guan, Zhang, Haili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736568/
https://www.ncbi.nlm.nih.gov/pubmed/31551955
http://dx.doi.org/10.3389/fmicb.2019.01999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736568/
https://www.ncbi.nlm.nih.gov/pubmed/31551955
http://dx.doi.org/10.3389/fmicb.2019.01999

Ejemplares similares